News

Daiichi Sankyo collaborates with Maruishi Pharmaceutical

Clementia-bags

Japan’s Daiichi Sankyo Company and Maruishi Pharmaceutical Co. Ltd have signed an agreement to collaborate on the commercialization of the general anaesthesia analgesic, generic Remifentanil injection, for which Maruishi Pharmaceutical is Clementia-bagscurrently applying for a manufacture and marketing license. Remifentanil injection is widely used as an opioid analgesic (μ-opioid receptor agonist) to manage general anaesthesia. It is an ultra short-acting analgesic used for general anaesthesia characterized by its potent analgesic action together with its superior ability to rapidly regulate pain.

Once Maruishi Pharmaceutical has acquired a license for the manufacturing and marketing of this drug, the plan is for Maruishi Pharmaceutical to handle its manufacture and Daiichi Sankyo to handle its marketing, while both companies will jointly conduct promotion activities.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn3Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top